Behind The Idea #93: Ligand's Shots On Goal Target

Oct 8, 2019 · 46m 33s
Behind The Idea #93: Ligand's Shots On Goal Target
Description

Ligand Pharmaceuticals has been both a strong performer over the past decade and a target of short sellers for some time. The stock has struggled over the last 18 months,...

show more
Ligand Pharmaceuticals has been both a strong performer over the past decade and a target of short sellers for some time. The stock has struggled over the last 18 months, though, and Seeking Alpha author 8 Diamonds Advisors feels that the stock has become a strong buy again. The thesis rests on the company's shots on goal approach and its more diversified model. We discuss whether this holds up and what that means for investors.
Topics covered: 
3:15 - Key elements of 8 Diamonds Advisor's thesis and understanding the company's products
6:15 - "Shots on goal" - what does that mean and how does it work?
15:45 - The challenges in analyzing the business model
19:45 - Management's place in the thesis
24:15 - What's gone on the past few years?
26:45 - The short theses over the year
35:45 - The Promacta divestment and a share buyback (?!)
Learn more about your ad choices. Visit megaphone.fm/adchoices
show less
Information
Author Seeking Alpha
Organization Seeking Alpha
Website -
Tags
-

Looks like you don't have any active episode

Browse Spreaker Catalogue to discover great new content

Current

Podcast Cover

Looks like you don't have any episodes in your queue

Browse Spreaker Catalogue to discover great new content

Next Up

Episode Cover Episode Cover

It's so quiet here...

Time to discover new episodes!

Discover
Your Library
Search